ARTICLE | Company News
Pinnacle Biologics, AstraZeneca deal
June 30, 2008 7:00 AM UTC
AstraZeneca’s MedImmune Inc. subsidiary purchased an undisclosed amount in preferred convertible stock from Pinnacle. Further details were not disclosed. Pinnacle has exclusive rights to market and di...